STRATA Skin Sciences, Inc. (NASDAQ: SSKN) has announced the results of a groundbreaking study conducted in Japan, which ...
By understanding the essential role vitamins play in hair growth and scalp health, one can take proactive steps to prevent ...
STRATA Skin Sciences (SSKN) announces the results of a newly published study in Japan that further validates the technological advantages of ...
The annual meeting of the American Academy of Dermatology was held from March 7 to 11 in Orlando, Florida, and attracted ...
It’s time that insurance recognizes wigs as necessary medical expenses for those suffering from conditions like alopecia, ...
The topical form was approved for hair loss by the FDA in 1988, the first drug to win the agency's endorsement for male ...
For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...
Significantly more patients receiving baricitinib 2 mg, 4 mg had SALT score ≤20, ≤10 versus placebo at week 36 ...
Changes in nail colour, shape, or texture are not normal and can indicate underlying health issues, nutrient deficiencies, or ...
For adolescents with severe alopecia areata (AA), baricitinib is efficacious for hair regrowth, according to a study ...
Small amounts of a common antibiotic and anti-inflammatory drug can curb symptoms where a misplaced immune reaction (e.g., autoimmunity) can cause permanent hair loss, a new study shows.
Adolescents with alopecia areata achieve hair regrowth with 80% or more of scalp coverage while taking the Janus kinase inhibitor baricitinib, a phase 3 study finds.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results